Jacobs Levy Equity Management’s Regenxbio RGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-89,218	Closed	-$936K	–	1029
2024 Q3	$936K	Sell	89,218 -63,219	-41%	-$771K	﹤0.01%	731
2024 Q2	$1.78M	Sell	152,437 -139,904	-48%	-$2.18M	0.01%	623
2024 Q1	$6.16M	Sell	292,341 -402,843	-58%	-$7.17M	0.03%	386
2023 Q4	$12.5M	Buy	695,184 +132,793	+24%	+$2.34M	0.06%	276
2023 Q3	$9.26M	Buy	562,391 +1,493	+0.3%	+$27.1K	0.05%	270
2023 Q2	$11.2M	Sell	560,898 -71,480	-11%	-$1.38M	0.06%	262
2023 Q1	$12M	Buy	632,378 +605,255	+2,232%	+$13.4M	0.07%	260
2022 Q4	$615K	Buy	27,123 +16,531	+156%	+$374K	﹤0.01%	754
2022 Q3	$280K	Sell	10,592 -147,660	-93%	-$4.38M	﹤0.01%	899
2022 Q2	$3.91M	Sell	158,252 -16,660	-10%	-$416K	0.03%	462
2022 Q1	$5.8M	Buy	+174,912	New	+$4.86M	0.04%	385
2021 Q3	–	Sell	-179,521	Closed	-$6.97M	–	1114
2021 Q2	$6.97M	Sell	179,521 -11,943	-6%	-$427K	0.05%	372
2021 Q1	$6.53M	Buy	191,464 +164,416	+608%	+$7.01M	0.05%	379
2020 Q4	$1.23M	Sell	27,048 -1,518	-5%	-$53K	0.01%	672
2020 Q3	$786K	Sell	28,566 -5,261	-16%	-$172K	0.01%	706
2020 Q2	$1.25M	Buy	+33,827	New	+$1.26M	0.01%	627